Document Detail

Attention to threats and combat-related posttraumatic stress symptoms: prospective associations and moderation by the serotonin transporter gene.
MedLine Citation:
PMID:  23407816     Owner:  NLM     Status:  MEDLINE    
IMPORTANCE: Combat places soldiers at risk for posttraumatic stress disorder (PTSD). The excessive rates of PTSD and other adjustment disorders in soldiers returning home make it imperative to identify risk and resilience factors that could be targeted by novel therapeutic treatments.
OBJECTIVE: To investigate the interplay among attention to threat, combat exposure, and other risk factors for PTSD symptoms in soldiers deployed to combat.
DESIGN AND SETTING: Longitudinal prospective study of Israeli Defense Force infantry soldiers carried out in 2008 through 2010. Repeated measurements during a 1-year period included baseline and predeployment data collected in training camps and deployment data collected in the combat theater.
PARTICIPANTS: Infantry soldiers (1085 men; mean age, 18.8 years).
MAIN OUTCOME MEASURES: Postcombat PTSD symptoms. RESULTS Soldiers developed threat vigilance during combat deployment, particularly when they were exposed to high-intensity combat, as indicated by faster response times to targets appearing at the location of threat relative to neutral stimuli (P < .001). Threat-related attention bias also interacted with combat exposure to predict risk for PTSD (P < .05). Bias toward threat at recruitment (P < .001) and bias away from threat just before deployment (P < .05) predicted postcombat PTSD symptoms. Moreover, these threat-related attention associations with PTSD were moderated by genetic and environmental factors, including serotonin transporter (5-HTTLPR) genotype.
CONCLUSIONS AND RELEVANCE: Combat exposure interacts with threat-related attention to place soldiers at risk for PTSD, and interactions with other risk factors account for considerable variance in PTSD vulnerability. Understanding these associations informs research on novel attention bias modification techniques and prevention of PTSD.
Ilan Wald; Kathryn A Degnan; Elena Gorodetsky; Dennis S Charney; Nathan A Fox; Eyal Fruchter; David Goldman; Gad Lubin; Daniel S Pine; Yair Bar-Haim
Related Documents :
24343546 - Comparing trends in esophageal adenocarcinoma incidence and lifestyle factors between t...
24910356 - Relationship between atherosclerotic risk factors and aortic plaques in patients with f...
23991026 - Analysis of factors that determine weight gain during smoking cessation therapy.
10927986 - Hypertension in women.
15864136 - Microsatellite polymorphisms in the epidermal growth factor receptor (egfr) gene and th...
20441856 - Teen driving exposure in michigan: demographic and behavioral characteristics.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  JAMA psychiatry     Volume:  70     ISSN:  2168-6238     ISO Abbreviation:  JAMA Psychiatry     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-04-04     Completed Date:  2013-05-31     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  101589550     Medline TA:  JAMA Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  401-8     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Military Personnel / psychology*
Neuropsychological Tests
Prospective Studies
Serotonin Plasma Membrane Transport Proteins / genetics*,  physiology
Stress Disorders, Post-Traumatic / etiology*,  genetics,  psychology
Young Adult
Reg. No./Substance:
0/SLC6A4 protein, human; 0/Serotonin Plasma Membrane Transport Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II an...
Next Document:  Continuous flame aerosol synthesis of carbon-coated nano-LiFePO(4) for Li-ion batteries.